Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Decker

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Chemmedchem|January 26, 2016
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease TherapyYoussef Dgachi, Lhassane Ismaili, Damijan Knez, et al.
ACS Chemical Neuroscience|July 26, 2022
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB<sub>1</sub>R) "Cis-On" AgonistDiego A Rodríguez-Soacha, Sophie A M Steinmüller, Ali Işbilir, et al.
Biochemistry and Biophysics Reports|July 30, 2025
Discovery and optimization of a guanylhydrazone-based small molecule to replace bFGF for cell culture applicationsMikhail Feofanov, Gerrit Martin Daubner, Andrea Saltalamacchia, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Chemmedchem|December 25, 2014
Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybridsMohamed Benchekroun, Manuela Bartolini, Javier Egea, et al.
European Journal of Medicinal Chemistry|August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effectsCaterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Molecular Cell|September 30, 2019
Mediator Condensates Localize Signaling Factors to Key Cell Identity GenesAlicia V Zamudio, Alessandra Dall'Agnese, Jonathan E Henninger, et al.
Nature|August 9, 2019
Pol II phosphorylation regulates a switch between transcriptional and splicing condensatesYang Eric Guo, John C Manteiga, Jonathan E Henninger, et al.
Genes & Development|October 16, 2020
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcriptionJenna K Rimel, Zachary C Poss, Benjamin Erickson, et al.
Science (New York, N.Y.)|June 20, 2020
Partitioning of cancer therapeutics in nuclear condensatesIsaac A Klein, Ann Boija, Lena K Afeyan, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Chemmedchem|January 26, 2016
Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease TherapyYoussef Dgachi, Lhassane Ismaili, Damijan Knez, et al.
ACS Chemical Neuroscience|July 26, 2022
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB<sub>1</sub>R) "Cis-On" AgonistDiego A Rodríguez-Soacha, Sophie A M Steinmüller, Ali Işbilir, et al.
Biochemistry and Biophysics Reports|July 30, 2025
Discovery and optimization of a guanylhydrazone-based small molecule to replace bFGF for cell culture applicationsMikhail Feofanov, Gerrit Martin Daubner, Andrea Saltalamacchia, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Chemmedchem|December 25, 2014
Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybridsMohamed Benchekroun, Manuela Bartolini, Javier Egea, et al.
European Journal of Medicinal Chemistry|August 21, 2021
From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effectsCaterina Pont, Tiziana Ginex, Christian Griñán-Ferré, et al.
Molecular Cell|September 30, 2019
Mediator Condensates Localize Signaling Factors to Key Cell Identity GenesAlicia V Zamudio, Alessandra Dall'Agnese, Jonathan E Henninger, et al.
Nature|August 9, 2019
Pol II phosphorylation regulates a switch between transcriptional and splicing condensatesYang Eric Guo, John C Manteiga, Jonathan E Henninger, et al.
Genes & Development|October 16, 2020
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcriptionJenna K Rimel, Zachary C Poss, Benjamin Erickson, et al.
Science (New York, N.Y.)|June 20, 2020
Partitioning of cancer therapeutics in nuclear condensatesIsaac A Klein, Ann Boija, Lena K Afeyan, et al.
Pageof 18